New Hope: CRISPR Tech Tackles Sickle Cell
Unraveling how CRISPR technology is making a significant impact in the battle against Sickle Cell Disease. Key Takeaways FDA Approval of Casgevy and Lyfgenia: The U.S. Food and Drug Administration (FDA) has approved two groundbreaking cell-based gene therapies, Casgevy and Lyfgenia, for treating sickle cell disease (SCD) in patients aged 12 and older. This marks […]
New Hope: CRISPR Tech Tackles Sickle Cell Read More »